Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines
William C. Kisseberth(The Ohio State University Wexner Medical Center), Ching‐Shih Chen(Karolinska Institutet)
Cited by 30
Related Papers
Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma
|PLoS ONE|2016|58
Thiazolidinediones Mimic Glucose Starvation in Facilitating Sp1 Degradation through the Up-Regulation of β-Transducin Repeat-Containing Protein
|Molecular Pharmacology|2009|50
Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis
|BMC Cancer|2017|46
Targeting the Oncogenic E3 Ligase Skp2 in Prostate and Breast Cancer Cells with a Novel Energy Restriction-Mimetic Agent
|PLoS ONE|2012|32
Biological activity of dihydroartemisinin in canine osteosarcoma cell lines
|American Journal of Veterinary Research|2008|27